Tranostat Tablet
By Tranostat
Rx
15 Tablet in a Strip

Composition
Tranexamic Acid(500mg)

Manufacturer - Ozone Pharmaceuticals Ltd
Ozone House, Block A-3, 1 LSC, Janak Puri, New Delhi – 110058

Expires on or after
August, 2025

liver
Tranostat Tablet appears to be safe for individuals with liver disease based on the limited data available. It is suggested that liver disease patients might not require a dosage adjustment when using Tranostat Tablet. It is important to consult your doctor to ensure the appropriate usage of this medication in relation to liver health.

kidney
Tranostat Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
When taking Tranostat Tablet, be cautious as it can lead to increased drowsiness when consumed with alcohol.

driving
Tranostat Tablet generally does not impact your driving ability.

pregnancy
Tranostat Tablet is considered safe during pregnancy based on animal studies showing no significant adverse effects, although human studies are limited.

breastfeeding
Tranostat Tablet is considered safe while breastfeeding. Limited data indicates no significant risk to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | BLOOD RELATED |
Action Class | Antifibrinolytic |
₹287
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024